FOLD logo

Amicus Therapeutics (FOLD)

Profile

Full Name

Amicus Therapeutics, Inc.

Ticker Symbol

FOLD

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 31, 2007

Indexes

Not included

Website

http://amicusrx.com

Employees

499

Key Details

Price

$6.80(+1.57%)

Market cap

$2.09B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$528.29M(+32.29% YoY)

Annual EPS

-$0.18(+64.71% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$6.80
FOLD price is $6.80

30-Day Relative Volume

0.82
FOLD 30-day relative volume is 0.82

Price Performance

Price Today change

+1.57%
FOLD price is up +1.57% today

Price YTD change

-27.76%
FOLD price is down -27.76% since January 1st

Price 1-year change

-35.5%
FOLD price is down -35.5% year-on-year

Price 3-year change

-16.91%
FOLD price is down -16.91% over the past 3 years

Price Range

Price All-time high

$25.39
FOLD price is currently -73.20% below its historical high of $25.39

Price 3-year low

$5.91
FOLD price is currently +15.14% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.09B
FOLD market capitalization is $2.09 billion

Market cap 3-year change

-8.88%
FOLD market capitalization is down -8.88% over the past 3 years

Market cap All-time high

$6.49B
FOLD market capitalization is currently -67.77% below its historical high of $6.49 billion

Market cap sector rank

83.88%
FOLD market capitalization is higher than 83.88% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+3.74%
FOLD shares outstanding is up +3.74% year-on-year

Shares Outstanding 3-Year Change

+9.67%
FOLD shares outstanding is up +9.67% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.66
FOLD beta is 0.66

200-day SMA

$10.02
FOLD price is currently -32.05% below its 200-day simple moving average

50-day SMA

$8.65
FOLD price is currently -21.34% below its 50-day simple moving average

RSI

28.56
FOLD 14-day relative strength index is 28.56

Volume

0.82
FOLD 30-day relative volume is 0.82

ATR

$0.40
FOLD average true range is $0.40

10-day Historical Volatility

61.54%
FOLD 10-day historical volatility is 61.54%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$528.29M
FOLD annual revenue is $528.29 million

Revenue Analysts estimate

$631.00M
FOLD annual revenue is currently -16.28% lower than the consensus analysts' forecast

Revenue 1-year change

+32.29%
FOLD annual revenue is up +32.29% year-on-year

Revenue Sector rank

74.69%
FOLD annual revenue is higher than 74.69% of companies in Healthcare sector

EPS

EPS

-$0.18
FOLD annual earnings per share is -$0.18

EPS Analysts estimate

$0.50
FOLD annual earnings per share is currently -135.74% lower than the consensus analysts' forecast

EPS 1-year change

+64.71%
FOLD annual earnings per share is up +64.71% year-on-year

EPS Sector rank

78.02%
FOLD annual earnings per share is higher than 78.02% of companies in Healthcare sector

Profit

Gross profit

$475.35M
FOLD annual gross profit is $475.35 million

Gross margin

89.98%
FOLD annual gross profit margin is 89.98%

Operating profit

$34.06M
FOLD annual operating income is $34.06 million

Operating margin

6.45%
FOLD annual operating profit margin is 6.45%

Net income

-$56.11M
FOLD annual net profit is -$56.11 million

Net margin

-10.62%
FOLD annual net profit margin is -10.62%

Expenses

Total expenses

$494.23M
FOLD annual total expenses is $494.23 million

Operating expenses

$441.29M
FOLD annual total operating expenses is $441.29 million

Cost of goods sold

$52.94M
FOLD annual cost of goods sold is $52.94 million

Selling, general & administrative expenses

$323.38M
FOLD annual SGA is $323.38 million

Depreciation and amortization

$8.55M
FOLD annual depreciation & amortization is $8.55 million

Interest expense

$49.60M
FOLD annual interest expense is $49.60 million

Income tax

$27.35M
FOLD annual income tax is $27.35 million

EBIT & EBITDA

EBIT

$20.84M
FOLD annual earnings before interest & taxes is $20.84 million

EBITDA

$29.39M
FOLD annual EBITDA is $29.39 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$785.03M
FOLD annual total assets is $785.03 million

Non current assets

$280.30M
FOLD annual long term assets is $280.30 million

Current assets

$504.74M
FOLD annual total current assets is $504.74 million

Cash and cash equivalents

$213.75M
FOLD annual cash & cash equivalents is $213.75 million

Accounts receivable

$101.10M
FOLD annual accounts receivable is $101.10 million

Inventory

$118.78M
FOLD annual inventory is $118.78 million

Liabilities

Total liabilities

$590.99M
FOLD annual total liabilities is $590.99 million

Long term liabilities

$442.29M
FOLD annual total long term liabilities is $442.29 million

Current liabilities

$148.70M
FOLD annual total current liabilities is $148.70 million

Accounts payable

$12.95M
FOLD annual accounts payable is $12.95 million

Debt

Total debt

$443.64M
FOLD annual total debt is $443.64 million

Total debt 1-year change

-0.32%
FOLD annual total debt is down -0.32% year-on-year

Long term debt

$435.19M
FOLD annual long term debt is $435.19 million

Short term debt

$8.46M
FOLD annual short term debt is $8.46 million

Equity & Capital

Shareholders equity

$194.04M
FOLD annual stockholders equity is $194.04 million

Book value

$194.04M
FOLD annual book value is $194.04 million

Retained earnings

-$2.74B
FOLD annual retained earnings is -$2.74 billion

Working capital

$356.03M
FOLD annual working capital is $356.03 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$33.89M
FOLD annual cash flow from operations is -$33.89 million

Cash from operations 1-year change

+50.95%
FOLD annual cash flow from operations is up +50.95% year-on-year

Cash from investing

-$560.00K
FOLD annual cash flow from investing activities is -$560.00 thousand

Cash from investing 1-year change

-100.57%
FOLD annual cash flow from investing activities is down -100.57% year-on-year

Cash from financing

$5.12M
FOLD annual cash flow from financing activities is $5.12 million

Cash from financing 1-year change

-91.7%
FOLD annual cash flow from financing activities is down -91.7% year-on-year

CAPEX

CAPEX

$3.55M
FOLD annual capital expenditures is $3.55 million

CAPEX 1-year change

-52.24%
FOLD annual capital expenditures is down -52.24% year-on-year

Free Cash Flow

Free cash flow

-$37.44M
FOLD annual free cash flow is -$37.44 million

Free cash flow 1-year change

+51.07%
FOLD annual free cash flow is up +51.07% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

89.98%
FOLD annual gross profit margin is 89.98%

Operating margin

6.45%
FOLD annual operating profit margin is 6.45%

Net margin

-10.62%
FOLD annual net profit margin is -10.62%

ROA & ROE

ROA

-7.18%
FOLD annual return on assets is -7.18%

ROE

-31.68%
FOLD annual return on equity is -31.68%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
FOLD price to earnings ratio value is unknown

PE ratio Sector rank

-
FOLD price to earnings ratio is unknown

PB Ratio

PB ratio

10.77
FOLD price to book ratio is 10.77

PB ratio Sector rank

93.74%
FOLD price to book ratio is higher than 93.74% of companies in Healthcare sector

PS Ratio

PS ratio

3.96
FOLD price to sales ratio is 3.96

PS ratio Sector rank

60.64%
FOLD price to sales ratio is higher than 60.64% of companies in Healthcare sector

Enterprise value

Enterprise value

$2.32B
FOLD enterprise value is $2.32 billion

Enterprise value Sector rank

83.57%
FOLD enterprise value is higher than 83.57% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

78.96
FOLD EV/EBITDA is 78.96

EV/EBITDA Sector rank

98.35%
FOLD EV/EBITDA is higher than 98.35% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.39
FOLD annual current ratio is 3.39

Quick ratio

2.60
FOLD annual quick ratio is 2.60

Leverage

Debt to equity

2.01
FOLD annual debt to equity ratio is 2.01

Interest coverage ratio

0.42
FOLD annual interest coverage ratio is 0.42

Risk & Stability

Piotroski F-Score

4
FOLD piotroski f-score is 4

Altman Z-Score

-1.46
FOLD altman z-score is -1.46

Analyst ratings

Recent major analysts updates

Feb 20, 25 Wells Fargo
Overweight
Feb 20, 25 Needham
Hold
Jan 15, 25 Cantor Fitzgerald
Overweight
Jan 13, 25 Needham
Hold
Dec 13, 24 Morgan Stanley
Equal-Weight
Nov 12, 24 JP Morgan
Overweight
Nov 7, 24 UBS
Buy
Nov 7, 24 Needham
Hold
Nov 7, 24 Guggenheim
Buy
Nov 7, 24 Cantor Fitzgerald
Overweight

Institutional Ownership

Similar stocks

VCEL logo
Vericel (VCEL)
LGND logo
Ligand Pharmaceuticals Incorporated (LGND)
SEM logo
Select Medical Holdings (SEM)
IBRX logo
ImmunityBio (IBRX)
RXRX logo
Recursion Pharmaceuticals (RXRX)
CERT logo
Certara (CERT)
LMAT logo
LeMaitre Vascular (LMAT)
BHVN logo
Biohaven (BHVN)
LIVN logo
LivaNova (LIVN)
  • What is the ticker symbol for Amicus Therapeutics?
  • Does Amicus Therapeutics pay dividends?
  • What sector is Amicus Therapeutics in?
  • What industry is Amicus Therapeutics in?
  • What country is Amicus Therapeutics based in?
  • When did Amicus Therapeutics go public?
  • Is Amicus Therapeutics in the S&P 500?
  • Is Amicus Therapeutics in the NASDAQ 100?
  • Is Amicus Therapeutics in the Dow Jones?
  • When was Amicus Therapeutics's last earnings report?
  • When does Amicus Therapeutics report earnings?
  • Should I buy Amicus Therapeutics stock now?

What is the ticker symbol for Amicus Therapeutics?

The ticker symbol for Amicus Therapeutics is NASDAQ:FOLD

Does Amicus Therapeutics pay dividends?

No, Amicus Therapeutics does not pay dividends

What sector is Amicus Therapeutics in?

Amicus Therapeutics is in the Healthcare sector

What industry is Amicus Therapeutics in?

Amicus Therapeutics is in the Biotechnology industry

What country is Amicus Therapeutics based in?

Amicus Therapeutics is headquartered in United States

When did Amicus Therapeutics go public?

Amicus Therapeutics's initial public offering (IPO) was on May 31, 2007

Is Amicus Therapeutics in the S&P 500?

No, Amicus Therapeutics is not included in the S&P 500 index

Is Amicus Therapeutics in the NASDAQ 100?

No, Amicus Therapeutics is not included in the NASDAQ 100 index

Is Amicus Therapeutics in the Dow Jones?

No, Amicus Therapeutics is not included in the Dow Jones index

When was Amicus Therapeutics's last earnings report?

Amicus Therapeutics's most recent earnings report was on Feb 19, 2025

When does Amicus Therapeutics report earnings?

The next expected earnings date for Amicus Therapeutics is May 9, 2025

Should I buy Amicus Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page